Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 235Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Gowling Lafleur Henderson LLP

02 2Hoffmann-La Roche Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Capecitabine

Brand Name : XELODA

Patent Number : 1327358

Filing Date : 1988-11-02

Strength per Unit : 150 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-03-01

Date Granted : 1994-03-01

blank

02

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Capecitabine

Brand Name : XELODA

Patent Number : 1327358

Filing Date : 1988-11-02

Strength per Unit : 500 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-03-01

Date Granted : 1994-03-01

blank

03

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Capecitabine

Brand Name : XELODA

Patent Number : 2103324

Filing Date : 1993-11-17

Strength per Unit : 150 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-17

Date Granted : 1997-12-23

blank

04

arrow
CPhI India 2024
Not Confirmed
arrow
CPhI India 2024
Not Confirmed

Capecitabine

Brand Name : XELODA

Patent Number : 2103324

Filing Date : 1993-11-17

Strength per Unit : 500 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-17

Date Granted : 1997-12-23

blank